Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Simone

Showing results (341-350 of 372) with videos related to

Pageof 38
Sort By:
Urologic Oncology|May 17, 2024
Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group)Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
World Journal of Urology|November 26, 2025
Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma in the setting of clinical node positive disease: analysis of the ROBUUST registryMargaret F Meagher, Zhenjie Wu, Antonio Franco, et al.
European Urology Focus|May 20, 2025
Long-term Oncological Outcomes for Patients with Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin (BCG): A Comparative Analysis of Adequate Versus Inadequate BCG TreatmentPietro Scilipoti, Mattia Longoni, Mario de Angelis, et al.
BJU International|September 12, 2024
Robot-assisted nephroureterectomy: surgical and mid-term oncological outcomes in over 1100 patients (ROBUUST 2.0 collaborative group)Francesco Ditonno, Antonio Franco, Zhenjie Wu, et al.
Urologic Oncology|February 26, 2022
Variant histologies in bladder cancer: Does the centre have an impact in detection accuracy?Alessia Cimadamore, Chiara Lonati, Ettore Di Trapani, et al.
Urologic Oncology|March 25, 2025
Neoadjuvant chemotherapy prior to radical nephroureterectomy: Survival outcomes and recurrence patterns by pathologic node statusFarshad Sheybaee Moghaddam, Rashid K Sayyid, Alireza Ghoreifi, et al.
Journal of Clinical Medicine|October 16, 2024
Surgical Experience and Functional Outcomes after Laparoscopic and Robot-Assisted Partial Nephrectomy: Results from a Multi-Institutional CollaborationCarlo Andrea Bravi, , Paolo Dell'Oglio, et al.
BJU International|February 19, 2025
Outcomes of BCG vs upfront radical cystectomy for high-risk non-muscle-invasive bladder cancerPietro Scilipoti, Mattia Longoni, Mario de Angelis, et al.
European Urology|December 3, 2023
Atlas of Intracorporeal Orthotopic Neobladder Techniques After Robot-assisted Radical Cystectomy and Systematic Review of Clinical OutcomesFederico Piramide, Filippo Turri, Daniele Amparore, et al.
Minerva Urology and Nephrology|April 4, 2025
A pretreatment nomogram to predict muscle-invasiveness in high-risk upper tract urothelial carcinoma (ROBUUST 2.0 collaborative group)Francesco Ditonno, Antonio Franco, Eugenio Bologna, et al.
Pageof 38

Showing results (341-350 of 372) with videos related to

Sort By:
Pageof 38
Urologic Oncology|May 17, 2024
Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group)Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
World Journal of Urology|November 26, 2025
Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma in the setting of clinical node positive disease: analysis of the ROBUUST registryMargaret F Meagher, Zhenjie Wu, Antonio Franco, et al.
European Urology Focus|May 20, 2025
Long-term Oncological Outcomes for Patients with Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin (BCG): A Comparative Analysis of Adequate Versus Inadequate BCG TreatmentPietro Scilipoti, Mattia Longoni, Mario de Angelis, et al.
BJU International|September 12, 2024
Robot-assisted nephroureterectomy: surgical and mid-term oncological outcomes in over 1100 patients (ROBUUST 2.0 collaborative group)Francesco Ditonno, Antonio Franco, Zhenjie Wu, et al.
Urologic Oncology|February 26, 2022
Variant histologies in bladder cancer: Does the centre have an impact in detection accuracy?Alessia Cimadamore, Chiara Lonati, Ettore Di Trapani, et al.
Urologic Oncology|March 25, 2025
Neoadjuvant chemotherapy prior to radical nephroureterectomy: Survival outcomes and recurrence patterns by pathologic node statusFarshad Sheybaee Moghaddam, Rashid K Sayyid, Alireza Ghoreifi, et al.
Journal of Clinical Medicine|October 16, 2024
Surgical Experience and Functional Outcomes after Laparoscopic and Robot-Assisted Partial Nephrectomy: Results from a Multi-Institutional CollaborationCarlo Andrea Bravi, , Paolo Dell'Oglio, et al.
BJU International|February 19, 2025
Outcomes of BCG vs upfront radical cystectomy for high-risk non-muscle-invasive bladder cancerPietro Scilipoti, Mattia Longoni, Mario de Angelis, et al.
European Urology|December 3, 2023
Atlas of Intracorporeal Orthotopic Neobladder Techniques After Robot-assisted Radical Cystectomy and Systematic Review of Clinical OutcomesFederico Piramide, Filippo Turri, Daniele Amparore, et al.
Minerva Urology and Nephrology|April 4, 2025
A pretreatment nomogram to predict muscle-invasiveness in high-risk upper tract urothelial carcinoma (ROBUUST 2.0 collaborative group)Francesco Ditonno, Antonio Franco, Eugenio Bologna, et al.
Pageof 38